City

Houston (1)

Nijmegen (1)

Condition

Subacute Necrotizing Encephalomyelopathy (2)

Leigh Disease (1)

Leigh Syndrome (1)

Leigh's Necrotizing Encephalopathy (1)

MELAS (1)

Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation (1)

Mitochondrial Diseases (1)

Subacute Necrotizing Encephalomyopathy (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2 (1)

Sponsor

Khondrion BV (1)

The University of Texas Health Science Center, Houston (1)

Collaborator

Ardena (1)

Certara (1)

Europees Fonds voor Regionale Ontwikkeling (EFRO) (1)

Julius Clinical (1)

ProPharma Group (1)

Intervention

placebo (1)

sonlicromanol (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational [Patient Registry] (1)

subacute necrotizing encephalomyelopathy

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Leigh Syndrome, Leigh Disease, Leigh's Necrotizing Encephalopathy Trial in Houston

Recruiting

Leigh Syndrome
+4 more

Houston, Texas

The University of Texas Health Science Center at Houston

May 16, 2022

Mitochondrial Diseases, Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation, MELAS Trial in Nijmegen (Sonlicromanol, Placebo)

Recruiting

Mitochondrial Diseases
+3 more

Sonlicromanol
Placebo

Nijmegen, Gelderland, Netherlands

Radboud University Medical Center

Jan 26, 2022